$321.67 +5.61 (%) Biogen Idec Inc - NASDAQ

Oct. 24, 2014 | 04:00 PM

Partner Headlines

  1. Citi, Jefferies Weigh In On Biogen Idec Amid Q3 Earnings

    Benzinga | Oct. 23, 2014 | 11:25AM EST
  2. US Stock Futures Rise Ahead Of Earnings, Economic Data

    Benzinga | Oct. 23, 2014 | 07:41AM EST
  3. Leading Researchers Join Biogen Idec To Advance Drug Discovery For Neurodegenerative Diseases

    Benzinga | Oct. 23, 2014 | 07:31AM EST
  4. Better Biotechs Don't Satisfy

    IBD | Oct. 22, 2014 | 18:53PM EST
  5. Biotechs Show Fed Chief's Not Much Of A Stock Analyst

    IBD | Oct. 22, 2014 | 17:01PM EST
  6. Markets Reverse Early Morning Gains Following Canadian Shooting

    Benzinga | Oct. 22, 2014 | 16:43PM EST
  7. Major Indexes End Win Streak; Super Micro Surges

    IBD | Oct. 22, 2014 | 16:24PM EST
  8. Stocks Erase Modest Gains; Apple Flirts With Breakout

    IBD | Oct. 22, 2014 | 15:06PM EST
  9. Stocks Up at Midday; Super Micro Retakes Buy Point

    IBD | Oct. 22, 2014 | 12:06PM EST
  10. Biogen, Thermo Reports Disappoint; Abbott Accelerates

    IBD | Oct. 22, 2014 | 11:18AM EST
  11. Stocks Cling To Slender Advance; Boeing, Cree, Biogen Slide

    IBD | Oct. 22, 2014 | 10:31AM EST
  12. Morning Market Losers

    Benzinga | Oct. 22, 2014 | 09:55AM EST
  13. Benzinga's Top #PreMarket Losers

    Benzinga | Oct. 22, 2014 | 08:43AM EST
  14. UPDATE: Biogen Idec Posts Upbeat Q3 Results, Raises Earnings Forecast

    Benzinga | Oct. 22, 2014 | 07:30AM EST
  15. Earnings Scheduled For October 22, 2014

    Benzinga | Oct. 22, 2014 | 05:16AM EST
  16. Biogen Leads 5 Top Biotech Stocks As Earnings Loom

    IBD | Oct. 21, 2014 | 19:56PM EST
  17. Yahoo, Super Micro Rally After Hours

    IBD | Oct. 21, 2014 | 17:03PM EST
  18. Celgene Reports More Good Crohn's Disease Data

    IBD | Oct. 21, 2014 | 11:32AM EST
  19. Celgene's Crohn's Disease Drug Hits Its Marks

    IBD | Oct. 20, 2014 | 11:16AM EST
  20. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD | Oct. 18, 2014 | 08:02AM EST
  21. Baxter Q3 Beats As Hemophilia Drugs Fend Off Rivals

    IBD | Oct. 16, 2014 | 15:07PM EST
  22. IPO Stock Watch: Biotech Forward Pharma Falls On IPO

    IBD | Oct. 15, 2014 | 16:06PM EST
  23. Major Averages Pare Losses, Then Head Lower Again

    IBD | Oct. 15, 2014 | 12:01PM EST
  24. IBD 50: Medical, Internet Companies Top Q3 Estimates

    IBD | Oct. 13, 2014 | 19:15PM EST
  25. IPO Calendar: Biotech Companies Lead List Of 7 IPOs

    IBD | Oct. 13, 2014 | 16:33PM EST
  26. Which Fund Has The Most To Gain From Biogen Idec?

    Benzinga | Oct. 13, 2014 | 10:05AM EST
  27. IBD 50: Medical, Internet Companies Top Q3 Profit Estimates

    IBD | Oct. 10, 2014 | 18:45PM EST
  28. Most Top Industry Groups Fall Harder Than Market

    IBD | Oct. 10, 2014 | 17:58PM EST
  29. Biogen Idec Inc's Stock Is Set To Drop

    Benzinga | Oct. 9, 2014 | 07:26AM EST
  30. Second Oldest Stock Fund Is As Nimble As A Teenager

    IBD | Oct. 2, 2014 | 18:25PM EST
  31. Top Fund Buys: Chipotle, Allergan, Jazz, Gilead

    IBD | Oct. 2, 2014 | 18:25PM EST
  32. Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20%

    GuruFocus | Oct. 1, 2014 | 17:39PM EST
  33. Biogen Idec Inc Still Showing Relative Weakness Compared To Biotech Peers

    Benzinga | Sep. 30, 2014 | 15:17PM EST
  34. Biotech Stocks Rebound On Strong Earnings, New Drugs

    IBD | Sep. 29, 2014 | 18:32PM EST
  35. Large-Cap Tech, Biotech Names Hang Tough In Shaky Market

    IBD | Sep. 29, 2014 | 18:32PM EST
  36. New MS Drugs Offer Promise

    IBD | Sep. 26, 2014 | 18:56PM EST
  37. Multiple Sclerosis Drugs Could Transform Market Again

    IBD | Sep. 26, 2014 | 18:07PM EST
  38. Technology Stocks Slide But Other Sectors Hold Up Better

    IBD | Sep. 25, 2014 | 18:55PM EST
  39. A Few Reasons Why AbbVie's Momentum Will Continue

    GuruFocus | Sep. 25, 2014 | 17:53PM EST
  40. Stocks Get Hit Hard; GoPro, Skechers Buck Weakness

    IBD | Sep. 25, 2014 | 16:23PM EST
  41. Wave Of Selling Hits Stocks; IPO CyberArk Extends Gains

    IBD | Sep. 25, 2014 | 13:31PM EST
  42. Apple Fuels Tech Sell-Off; Valeant Bucks The Trend

    IBD | Sep. 25, 2014 | 11:34AM EST
  43. Stocks End Skid; Vertex, Alexion Lead Biotech Rebound

    IBD | Sep. 24, 2014 | 16:16PM EST
  44. Stocks Up In Afternoon; Hasbro Jumps On Disney Deal

    IBD | Sep. 24, 2014 | 15:05PM EST
  45. Acorda To Buy Civitas, Gains Parkinson's Disease Drug

    IBD | Sep. 24, 2014 | 13:27PM EST
  46. Stocks Hold Solid Gains; CyberArk Soars In Debut

    IBD | Sep. 24, 2014 | 13:20PM EST
  47. Most Big Cap 20 Stocks Near Entries, But Risks Exist

    IBD | Sep. 22, 2014 | 19:05PM EST
  48. Gilead's Zydelig Approved In EU; Imbruvica In Wings

    IBD | Sep. 19, 2014 | 12:17PM EST
  49. 2 Columbia Growth Funds Notch Impressive Three-Month Performance

    Benzinga | Sep. 18, 2014 | 10:52AM EST
  50. Nasdaq Falls Hard, But Apple Resilient On iPhone Orders

    IBD | Sep. 15, 2014 | 14:55PM EST
Trading Center